Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone for Postoperative Pregnancy in Endometriosis
NCT05467852Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Dec 2022
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, open-label trial of dydrogesterone in endometriosis (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Pregnancy Rate. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
dydrogesterone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05467852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467852.